Assessment of Cytochrome P450 Enzyme Inhibition and Inactivation in Drug Discovery and Development

E-ISSN： 1873-4294|11|4|382-403

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.4, 2011-02, pp. : 382-403

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolism Profiling, and Cytochrome P450 Inhibition & Induction in Drug Discovery

Current Topics in Medicinal Chemistry, Vol. 1, Iss. 5, 2001-11 ,pp. : 403-425

Bentham Science Publishers

Access to resources Recommend Favorite

The Evolution of Cytochrome P450 Enzymes as Biocatalysts in Drug Discovery and Development

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 18, 2013-09 ,pp. : 2254-2280

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of Cytochrome-P450 Inhibition (CYP) in Drug Discovery: A Medicinal Chemistry Perspective

Current Medicinal Chemistry, Vol. 19, Iss. 21, 2012-07 ,pp. : 3605-3621

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-Drug Interactions via Mechanism-Based Cytochrome P450 Inactivation: Points to Consider for Risk Assessment from In Vitro Data and Clinical Pharmacologic Evaluation

Current Drug Metabolism, Vol. 8, Iss. 5, 2007-06 ,pp. : 449-462

Bentham Science Publishers

Access to resources Recommend Favorite

Atypical Cytochrome P450 Kinetics: Implications for Drug Discovery

By Tracy Timothy S.

Drugs in R&D, Vol. 7, Iss. 6, 2006-01 ,pp. : 349-363

Adis International

Access to resources Recommend Favorite